Press release: Ncardia launches Ncyte® Microglia

Published on January 27, 2025
Press release: Ncardia launches Ncyte® Microglia

LEIDEN, THE NETHERLANDS, January 27, 2025: Ncardia, a global leader in human induced pluripotent stem cell (hiPSC) technology, today announced the launch of Ncyte® Microglia, a groundbreaking tool to advance research in neurodegenerative diseases and central nervous system (CNS) disorders.

Continue reading on website
Other news

Press release: Ncardia launches Ncyte® Heart in a Box

January 27, 2025
LEIDEN, THE NETHERLANDS, January 27, 2025: Ncardia, a leading human induced pluripotent stem cell (hiPSC) technology company, today announced the launch of Ncyte® Heart in a Box, a breakthrough 3D cardiac microtissue model designed to drive innovation in cardiovascular research and drug discovery.

Elevated Practice Solutions (EPS) to Support Greater New York Anesthesia Services

January 28, 2025
Elevated Practice Solutions (EPS) to Support Greater New York Anesthesia Services Jodi_Lewis Mon, 01/27/2025 - 18:58Read more about Elevated Practice Solutions (EPS) to Support Greater New York Anesthesia Services A joint venture between Mount Sinai Ambulatory Ventures and U.S.